Panion & Bf Biotech Inc. (TPE:1760)
52.80
-0.40 (-0.75%)
Oct 20, 2026, 1:30 PM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 4.53 billion as of October 20, 2026. It is the 23,020th most valuable company in the world and the 1,159th biggest in Taiwan. Its market cap has decreased by 20.48% in one year.
Market Cap
4.53B
Enterprise Value
4.69B
Revenue
2.11B
Global Rank
Country Rank
#1,159 Taiwan
PE Ratio
21.12
ChartMarket Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 4.53B, an increase of 747.04%. That is a compound annual growth rate of 10.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 4.53B | -16.19% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.39B |
| Orient Pharma | 5.89B |
| Formosa Laboratories | 5.80B |
| Alar Pharmaceuticals | 5.72B |
| Yoda Pharmaceuticals | 5.06B |
| LIWANLI Innovation | 4.57B |
| Orient EuroPharma | 3.98B |
| Easywell Biomedicals | 3.52B |